Dossier Preparation in CTD/ACTD/eCTD/National format. Must have Parenteral and partially OSD dosage forms exposure.

Experience in IPQA,QMS, Qualification & validation. Must having experience of API Pharma Industries.

Adequate understanding on respective authority guidance and filing of new product and post approval changes. Review of documents related to product registration and dossier submission leading to faster approval

Graduation : B.Pharm with post-graduation : M.Pharm / MBA (Pharma Management). Develop and implement brand strategies and marketing plans.

Environment monitoring of aseptic area, Water sampling and testing, Sterility testing, Bioburden analysis and MLT analysis, Bacterial endotoxin test, Media preparation and handling.

Skilled in Batch Records, SOPs, BMR, and validation documentation. Proficient in calibration, routine equipment checks, and troubleshooting.

Good understanding of medical affairs function. Understanding of local regulatory policy and industrys code of practice related to drug registration, pharmaceutical promotion and clinical research.

Total 36 different medical devices are manufactured under Production Linked Incentive (PLI) Scheme for promoting domestic manufacturing of medical devices in India. These medical devices belong to different portfolios such as Imaging & Diagnostics, Critical Care & Emergency, Interventional CardioVascular, Renal Care Devices, Orthopaedic Implants, Oncology and specialist divisions.

Target set to increase the number of Jan Aushadhi Kendras to 25,000 by March 2027.

When most of us think of DNA, we have a vague idea it’s made up of genes that give us our physical features, our behavioural quirks, and keep our cells and organs running.

KEYNOTE-B15, also known as EV-304, is an open-label, randomized Phase 3 trial evaluating perioperative KEYTRUDA in combination with Padcev and surgery (radical cystectomy and pelvic lymph node dissection) versus neoadjuvant chemotherapy and surgery in patients with MIBC who are cisplatin-eligible.

The U.S. Food and Drug Administration (FDA) has granted approval to RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), marking a significant advancement in the treatment of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer

D.Pharm, Registration with MSPC / PCI Council is mandatory, preference will be given to candidates with experience.

Pharmacist with Diploma in Integrated Pharmacy with Computer Knowledge including MS Office, MS word, MS Power Point and MS Excel, MS access would be essential.

Diploma/ Certificate course in Ayurvedic pharmacy conducted by the Paschim Banga Ayurved Parishad. Computer knowledge including MS Officers Word, MS Excel, MS Power point) & Internet.

10 + 2 plus 2 years Diploma in Pharmacy. Registration with State Pharmacy Council.

Pharm.D or M.Pharm (Pharmacy Practice] with State Pharmacy Council registration. Prior Clinical Pharmacist experience.

Doctoral degree in science / Engineering / Technology / Pharma / MD / MS from a recognized University or equivalent.